Vesicant Characteristics of Oxapliplatin Following Antecubital Extravasation
- 31 August 2003
- journal article
- case report
- Published by Elsevier BV in Clinical Oncology
- Vol. 15 (5), 237-239
- https://doi.org/10.1016/s0936-6555(02)00338-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Oxaliplatin: A new agent for colorectal cancerCurrent Oncology Reports, 2001
- Extravasation of Oxaliplatin (Eloxatin®) – Clinical CourseOncology Research and Treatment, 2000
- Oxaliplatin-Induced Fever and Release of IL-6Oncology, 2000
- Severe Tissue Necrosis After Cisplatin Extravasation at Low Concentration: Possible “Immediate Recall Phenomenon”JNCI Journal of the National Cancer Institute, 1997
- Prevention and Management of Extravasation of Cytotoxic DrugsDrug Safety, 1995
- Etiology and treatment of chemotherapeutic agent extravasation injuries: a review.Journal of Clinical Oncology, 1987
- Mitomycin C extravasation injuriesCancer, 1983
- Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugsCancer Treatment Reviews, 1980
- ADRIAMYCIN EXTRAVASATIONPlastic and Reconstructive Surgery, 1978
- Skin ulcers due to adriamycinCancer, 1976